Unlocking rare diseases with nanopore sequencing
)
- Published on:
In this talk recorded at ACMG 2026, Wendy Chung shares clinical research from Boston Children's Hospital's BEACON project. The research demonstrates the potential for Oxford Nanopore any-length reads to overcome limitations of short read sequencing and provide clarity on short-read negative rare disease samples.
